IL17A and COVID-19: Consistently, it has been demonstrated that IL-17 plays a crucial role in the induction of leukocytosis and neutrophilia in inflamed airways and is also implicated in atherosclerosis, a major lethal consequence in critical COVID-19 patients59,60,.